When was BioDevek founded?

BioDevek was founded in 2014 and raised its 1st funding round 7 years after it was founded.

Where is BioDevek located?

BioDevek is headquartered in Boston, United States.

How many employees does BioDevek have?

As of Jun 30, 2026, the latest employee count at BioDevek is 6.

Is BioDevek a funded company?

BioDevek is a funded company, having raised an undisclosed amount across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 29, 2021.

When was the latest funding round of BioDevek?

BioDevek's latest funding was a $***** Grant (prize money) round on Aug 14, 2025, with participation from 1 investor.

Where does BioDevek rank among its competitors?

BioDevek ranks 20th amongst 82 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was LambdaVision, which secured $7M in Nov, 2025.

Who are the top competitors of BioDevek?

BioDevek's top competitors include RevBio, LambdaVision and Spiderwort. Among them, LambdaVision secured the most recent funding round in November, 2025.

BioDevek - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of next generation of surgical sealant solutions. The company uses a biodegradable and biocompatible adhesive material platform to develop surgical sealants. It is used to prevent leakage of body fluids from the suture line, such as blood following vascular surgeries and other minimally invasive surgeries.

Website: www.biodevek.com/
Email ID: *****@biodevek.com

Key Metrics

Founded Year

2014

Location

Boston, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Aug 14, 2025, $*****

Investors

MedTech Innovator & 2 more

Ranked

20^th among 82 active competitors

Employee Count

6 as on Jun 30, 2026

Similar Companies

RevBio & 99 more

View BioDevek's full profile

BioDevek has raised funding over 5 rounds. Its first funding round was on Sep 29, 2021. Its latest funding round was a Grant (prize money) round on Aug 14, 2025 for $*****. 1 investor participated in its latest round. BioDevek has 3 institutional investors.

Here is the list of recent funding rounds of BioDevek:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 14, 2025	2367539	Grant (prize money)	5099685	6092939	5335204	6259456
Apr 07, 2025	6432624	Grant (prize money)	1788935	1539300	5236867	National Science Foundation
Jun 01, 2024	9172245	Grant (prize money)	5159996	6112682	7470915	HHS

Access funding benchmarks and valuations. Sign up today!

View details of BioDevek's funding rounds and investors

The founders of BioDevek is Elazer R Edelman.

Here are the details of BioDevek's key team members:

Elazer R Edelman: Co-Founder of BioDevek.
Contact Info: 1 email address

View details of BioDevek's Founder profiles and Board Members

BioDevek's employee count trend

BioDevek has 6 employees as of Jun 26. Here is BioDevek's employee count trend over the years:

Uncover BioDevek's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioDevek include RevBio, LambdaVision and Spiderwort. Here is the list of Top 10 competitors of BioDevek, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	RevBio 2014, Lowell (United States), Series B	Developer of synthetic adhesive used for bone/dental repair	$27.5M	Pacific Dental Services, MassChallenge & 4 others	63/100
2nd	LambdaVision 2009, Farmington (United States), Public	Provider of a protein-based retinal prosthesis for retinal degenerative diseases	$7.65M	Seven Seven Six, Aurelia Foundry & 9 others	57/100
3rd	Spiderwort 2017, Ottawa (Canada), Series A	Developer of plant-based biomaterials for repair and regeneration of tissues	$16.1M	Horizons Ventures, Flucas Ventures & 10 others	54/100
4th	TYBR Health 2020, Houston (United States), Series A	Provider of regenrative medicine for post surgical scarring	$8.35M	Y Combinator, Eight Capital Management & 1 others	51/100
5th	CGbio 2006, Seongnam-si (South Korea), Unfunded	Solutions for the spectrum of spinal disorders, dentistry, dermal filer and wound management.	-	-	50/100
6th	ProFibrix 2004, Leiden (Netherlands), Acquired	Powdered fibrin sealant for surgical bleeding	$33M	Gilde Healthcare, Index Ventures & 3 others	47/100
7th	Dimension Inx 2017, Chicago (United States), Series A	Provider of 3D bio materials for regenerative medicine	$17.6M	Prime Movers Lab, KdT Ventures & 11 others	47/100
8th	HTL Biotechnology 1992, Javene (France), Acquired	Developer of biopolymers for therapy purposes	-	-	45/100
9th	Cousin Surgery 1848, Wervicq Sud (France), Unfunded	Manufacturer of implantable textile medical devices for spine and visceral surgery. It develops innovative implants to advance visceral and spine surgery, focusing on preserving mobility and reducing post-operative pain. The company collaborates closely with surgeons and utilizes unique expertise in implantable textiles. Its product portfolio includes solutions for various surgical specialties, such as orthopedics, uro-gynecology, and bariatric surgery, along with adhesion prevention and hemostasis products. The company also offers subcontracting services and technological support.	-	Turenne Groupe, Nord Capital Partenaires	45/100
10th	Neomend 1999, Irvine (United States), Acquired	Provider of air leak sealant for thoracic surgery	$38.8M	Novo Holdings, Blackstone & 4 others	43/100
20th	BioDevek 2014, Boston (United States), Funding Raised	Developer of next generation of surgical sealant solutions	-	MedTech Innovator, National Science Foundation ... & 1 others	37/100